Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

FirstEnergy Receives Analyst Upgrade Amid Infrastructure Push

Felix Baarz by Felix Baarz
August 31, 2025
in Analysis, Energy & Oil
0
FirstEnergy Stock
0
SHARES
262
VIEWS
Share on FacebookShare on Twitter

FirstEnergy shares gained analyst confidence as Barclays elevated its rating for the utility company from “Equal Weight” to “Overweight.” The financial institution simultaneously raised its price target from $43 to $49 per share, suggesting a potential 12 percent upside from current levels.

Financial Performance and Outlook

The company’s second-quarter results, reported in July, demonstrated resilience. FirstEnergy posted core earnings of $0.52 per share, exceeding the consensus estimate of $0.50. While revenue of $3.4 billion slightly missed the projected $3.45 billion, management reaffirmed its full-year guidance. The company maintains its core EPS forecast range of $2.40 to $2.60 for the year, with leadership expressing confidence in achieving the upper end of this projection. Long-term objectives include delivering annual earnings growth of 6-8 percent through 2029.

Barclays’ upgraded assessment reflects growing market optimism. The average price target among fifteen covering analysts now stands at $46.31, implying approximately 6.2 percent growth potential. Targets vary significantly across institutions, ranging from $44 to $50 per share.

Strategic Investments and Expansion

FirstEnergy is aggressively advancing its infrastructure modernization strategy through its Energize365 initiative. The comprehensive program calls for $28 billion in capital investments between 2025 and 2029, with $5 billion allocated specifically for 2025 projects.

Current infrastructure developments include a significant reliability project in Adams County, Pennsylvania, where subsidiary MAIT is constructing a new substation and 115-kilovolt transmission line. This $26 million investment will enhance service stability for approximately 2,300 customers.

Should investors sell immediately? Or is it worth buying FirstEnergy?

The company is also strengthening its leadership team to support these expansion efforts. Brooke Trammell will assume the newly created position of Vice President for Transmission Strategy beginning in September, overseeing the company’s grid modernization initiatives.

Institutional Activity and Shareholder Returns

Institutional investors demonstrated mixed positioning during the first quarter. Ameriprise Financial reduced its stake by 56.2 percent, while other major institutions including Vanguard Group, Boston Partners, and Soroban Capital expanded their holdings.

Shareholders continue to benefit from consistent dividend distributions. The company confirmed its quarterly dividend of $0.445 per share, with the next payment scheduled for September 1. This translates to an annualized distribution of $1.78 per share.

Regulatory Progress and Customer Programs

FirstEnergy recently achieved a significant legal victory when an appeals court halted the release of internal investigations in a class action lawsuit in August, effectively dismissing the case.

The company continues to support customers through various assistance programs:
* Maryland customers will receive energy bill credits beginning September 2025
* Ohio’s hardship program offers up to $500 in assistance through September
* Recent workforce adjustments affected fewer than 50 support positions, with no customer-facing roles impacted

Ad

FirstEnergy Stock: Buy or Sell?! New FirstEnergy Analysis from February 8 delivers the answer:

The latest FirstEnergy figures speak for themselves: Urgent action needed for FirstEnergy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

FirstEnergy: Buy or sell? Read more here...

Tags: FirstEnergy
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Quanterix Stock
Analysis

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Next Post
Ontrak Stock

Ontrak Files for Chapter 7 Bankruptcy: Shareholders Face Total Loss

P3 Health Partners Stock

P3 Health Partners: Navigating Debt Pressures Amid Technical Buying Signals

Uranium Energy Stock

Uranium Energy Poised for Growth as US Policy Shifts Nuclear Fuel Strategy

Recommended

Biotechnology Stock Exchange

Analysts Bullish on Dynatrace with Price Targets on the Rise

2 years ago
The Trade Desk Stock

The Trade Desk Faces Mounting Pressure as Amazon Strikes Netflix Deal

5 months ago

Analyst Reaffirms Buy Rating on International Seaways with 66 Price Target

2 years ago
Biotechnology Stock Bull Market

KeyBanc Analyst Raises Price Target and Maintains Overweight Rating on Repligen NASDAQ RGEN

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Trending

Puma Biotechnology Stock
Earnings

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

by Jackson Burston
February 8, 2026
0

Investor attention is now firmly fixed on February 26, 2026, as Puma Biotechnology prepares to release its...

Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure
  • Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test
  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com